Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
66.60
-0.65 (-0.97%)
Nov 16, 2026, 5:35 PM CET

Pharma Mar Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
237.4221.39174.86158.15196.34229.83
Revenue Growth
32.42%26.61%10.56%-19.45%-14.57%-14.87%
Gross Profit
221.56209.13166.67148.54182.7213.39
Operating Income
50.4860.726.47-3.8342.0792.45
Net Income
68.3774.9926.131.1449.3692.86
Earnings Per Share
3.944.301.490.062.735.13
EPS Growth
-188.68%2382.56%-97.80%-46.78%-31.51%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Oncology
234.05221.35174.59156.84191.18224.67
RNA Interference (RNAi)
-0.040.260.120.030
Total
237.4221.39174.86158.15196.34229.83

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
176.29167.22154.53162.56182.42201.88
Total Debt
70.0749.4251.0843.6742.6349.33
Net Cash (Debt)
106.23117.81103.45118.89139.79152.55
Net Cash Growth
10.26%13.88%-12.99%-14.95%-8.36%9.86%
Net Cash Per Share
6.136.755.896.647.748.44

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
52.853.136.03-13.4538.3225.68
Capital Expenditures
-8.39-6.46-15.02-14.81-8.85-7.8
Free Cash Flow
44.4146.67-8.99-28.2529.4717.87
Free Cash Flow Growth
165.62%---64.87%-93.52%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
93.33%94.46%95.32%93.92%93.05%92.85%
Operating Margin
21.26%27.42%3.70%-2.42%21.43%40.22%
Pretax Margin
22.34%26.94%6.85%-2.29%22.30%41.39%
Profit Margin
28.80%33.87%14.94%0.72%25.14%40.40%
FCF Margin
18.71%21.08%-5.14%-17.87%15.01%7.78%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.0001.0000.8000.6500.6500.650
Dividend Per Share Growth
25.00%25.00%23.08%0%0%8.33%
Dividend Yield
1.50%1.35%1.01%1.55%1.02%1.13%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.8917.1953.17649.5123.4611.12
Forward PE
15.5324.0336.2967.7616.7412.76
P/FCF Ratio
26.0027.62--39.3057.78
PS Ratio
4.865.827.944.675.904.49